Mehmet Tarık Tatoğlu

11PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markersTumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 04, 2026
Sequential 18F-FDG and 68Ga-FAPI-04 PET/CT in Early Peritoneal Recurrence of Signet-Ring-Component Rectal Adenocarcinoma.

|Sep 02, 2026
Subcutaneous Adipose Tissue FDG Uptake is Associated with Systemic Inflammatory Indices Independent of Primary-Tumor Metabolic Burden in Breast Cancer.

|Jul 01, 2026
Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer.

|May 21, 2026
Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.

|Feb 09, 2026
Benign thyroid nodule mimicking residual disease on positron emission tomography/computed tomography in a patient with concurrent thyroid and gastric diffuse large B-cell lymphoma: the value of ultrasound-guided biopsy.

Mehmet Tarık Tatoğlu, Mehmet Sait Özsoy

|Jan 19, 2026
A Rare Case of Anti-Yo Positive Paraneoplastic Limbic Encephalitis Associated with Thyroid-Parathyroid Adenoma.

Ezgi Aslan, Asuman Orhan Varoglu, Begumhan Baysal

Pageof 2

Frequent Collaborators

2 joint publications

Ebru İbişoğlu

2 joint publications

Hatice Uslu

2 joint publications

Ferda Yerdelen Tatoğlu

1 joint publications

Ezgi Aslan